All Things Chemical
Bergeson & Campbell, PC
All Things Chemical is a podcast produced by Bergeson & Campbell, P.C. (B&C®), a Washington D.C. law firm focusing on chemical law, business, and litigation matters. All Things Chemical is hosted by Lynn L. Bergeson, managing partner of B&C. In each episode, we bring you intelligent, insightful, and engaging conversation about everything related to industrial, pesticidal, and specialty chemicals, as well as the law and business issues surrounding chemicals. Our incredibly talented team of lawyers, scientists, and consultants keep you abreast of the changing world of both domestic and international chemical regulation and provide analysis of the many intriguing and complicated issues surrounding this space.
Categorieën: Zakelijk
Luister naar de laatste aflevering:
This week I discuss with my colleague, Heather Blankinship, Senior Scientist/Regulatory Consultant for B&C and The Acta Group, and Senior Manager for B&C® Consortia Management, L.L.C. (BCCM) to discuss the value of coalition advocacy, and its essentiality in the chemical space, especially now.
Heather manages many chemical coalitions and does a masterful job of managing issues and people. When you think about it, engaging commercial competitors to align on advocacy involving critically important regulatory, testing, and science policy issues is daunting. It involves strong communication skills, strong people skills, a keen understanding of the substantive issues, and endless patience. Heather explains how she does what she does, extolls the virtues of consortia advocacy, discusses some of BCCM’s successes, and explains why she and BCCM are as busy as they are these days.
ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL QUESTIONS SHOULD BE ANSWERED DIRECTLY BY A LICENSED ATTORNEY PRACTICING IN THE APPLICABLE AREA OF LAW.
©2024 Bergeson & Campbell, P.C. All Rights Reserved
Vorige afleveringen
-
131 - Utility of Consortia Advocacy — A Conversation with Heather J. BlankinshipThu, 25 Apr 2024 - 0h
-
130 - Asbestos Reporting Rule — A Conversation with Richard E. Engler, Ph.D.Thu, 11 Apr 2024 - 0h
-
129 - FIFRA Hot Topic Issues — A Conversation with Jim AidalaThu, 28 Mar 2024 - 0h
-
128 - TSCA Section 8(a)(7) PFAS Reporting Rule — A Conversation with Richard E. Engler, Ph.D.Thu, 07 Mar 2024 - 0h
-
127 - Environmental, Social, and Governance (ESG) Standards — A Conversation with The Honorable Leo E. Strine, Jr.Thu, 22 Feb 2024
-
126 - TSCA Developments in 2024 — A Conversation with Richard E. Engler, Ph.D.Thu, 08 Feb 2024 - 0h
-
125 - What to Expect on Capitol Hill in 2024 — A Conversation with Jim AidalaThu, 25 Jan 2024 - 0h
-
124 - GRAS: Are Changes in Our Future? — A Conversation with Karin F. BaronThu, 11 Jan 2024 - 0h
-
123 - EPA’s Proposed Registration of a Sprayable RNAi Biopesticide — A Conversation with Meibao Zhuang, Ph.D.Thu, 14 Dec 2023 - 0h
-
122 - Community Outreach and Environmental Justice — A Conversation with Rachel James of the SELCThu, 30 Nov 2023 - 0h
-
121 - Rev 10 GHS — A Conversation with Karin F. BaronThu, 16 Nov 2023 - 0h
-
120 - TSCA Reform — Seven Years Later: Per- and Polyfluoroalkyl Substances (PFAS) SessionThu, 02 Nov 2023
-
119 - TSCA Reform — Seven Years Later: New Chemicals Review SessionThu, 26 Oct 2023
-
118 - TSCA Reform — Seven Years Later: Risk Management SessionThu, 19 Oct 2023
-
117 - TSCA Reform — Seven Years Later: Risk Evaluation SessionThu, 12 Oct 2023
-
116 - Lessons in Effective Government Advocacy — A Conversation with Mark WashkoThu, 28 Sep 2023 - 0h
-
115 - PMN Review and Orders — A Conversation with Richard E. Engler, Ph.D.Thu, 14 Sep 2023 - 0h
-
114 - Section 6 Advocacy and the Importance of Being Early — A Conversation with Richard E. Engler, Ph.D.Thu, 31 Aug 2023 - 0h
-
113 - Competitive Advantage of Product Stewardship — A Conversation with Catherine M. Croke, DBAThu, 17 Aug 2023 - 0h
-
112 - The Hazard Communication Standard — A Conversation with Lesa Rice-Jackson, CPPS, Ph.D.Thu, 03 Aug 2023 - 0h
-
111 - EPA Adds Two New Chemical Categories: What It Means to Chemical Innovators — A Conversation with Richard E. Engler, Ph.D.Thu, 20 Jul 2023 - 0h
-
110 - CLP Changes — A Conversation with Lee Bowers and Karin F. BaronThu, 06 Jul 2023 - 0h
-
109 - A Conversation with Rear Admiral Melissa Bert, Esquire (Ret.)Thu, 22 Jun 2023 - 0h
-
108 - A Conversation with Shanisha Y. Smith, EsquireThu, 08 Jun 2023 - 0h
-
107 - PFAS under REACH — A Conversation with Jane S. Vergnes, Ph.D.Thu, 25 May 2023 - 0h
-
106 - PMN Review and Orders — A Conversation with Richard E. Engler, Ph.D.Thu, 11 May 2023 - 0h
-
105 - TSCA: New and Old — A Conversation with the Legendary Robert M. SussmanThu, 27 Apr 2023 - 0h
-
104 - Modernization of Cosmetic Regulations Act of 2022 — A Conversation with Karin F. BaronThu, 13 Apr 2023 - 0h
-
103 - The East Palestine Train Derailment: Behind the Scenes with Three Former Government OfficialsThu, 30 Mar 2023 - 0h
-
102 - What is Product Stewardship’s Value to a Company? — A Conversation with Tina N. Armstrong, Ph.D.Thu, 16 Mar 2023 - 0h
-
101 - Product Stewardship, Supply Chain, and Downstream User Engagement — A Conversation with Catherine M. Croke, DBAThu, 02 Mar 2023 - 0h
-
100 - Health Canada’s Update to Rev 7/8 of GHS — A Conversation with Karin F. BaronThu, 16 Feb 2023 - 0h
-
99 - What to Expect on Capitol Hill and at EPA OCSPP in 2023 — A Conversation with Jim AidalaThu, 02 Feb 2023 - 0h
-
98 - What to Expect in Chemicals Policy and Regulation in 2023 — A Conversation with Richard E. Engler, Ph.D.Thu, 19 Jan 2023 - 0h
-
97 - EPA Adds Two New Chemical Categories: What It Means to Chemical Innovators — A Conversation with Richard E. Engler, Ph.D.Thu, 05 Jan 2023 - 0h
-
96 - TSCA Regulation of Articles: The Saga Continues — A Conversation with Richard E. Engler, Ph.D.Thu, 08 Dec 2022 - 0h
-
95 - Keeping up with CLP Changes — A Conversation with Karin F. BaronThu, 10 Nov 2022 - 0h
-
94 - Biotech’s Emergence in the EU and Globally — A Conversation with Dr. Claire SkentelberyThu, 27 Oct 2022 - 0h
-
93 - Misunderstood: The Excise Tax No One Likes or Understands — A Conversation with Douglas Charnas and Richard E. Engler, Ph.D.Thu, 13 Oct 2022 - 0h
-
92 - The New Era of Smarter Food Safety — A Conversation with Karin BaronThu, 29 Sep 2022 - 0h
-
91 - TSCA New Approach Methodologies — A Conversation with James W. CoxThu, 15 Sep 2022 - 0h
-
90 - Do We Need An Animal Protection Agency? — A Conversation with Prof. Delcianna J. WindersThu, 01 Sep 2022 - 0h
-
89 - Is There A New Chemical Bias? — A Conversation with Richard E. Engler, Ph.D.Thu, 18 Aug 2022 - 0h
-
88 - The National Tribal Toxics Council — A Conversation with Dianne Barton, Ph.D.Thu, 04 Aug 2022
-
87 - Tips for Working with Foreign Regulators in China — A Conversation with David Cragin, Ph.D.Thu, 21 Jul 2022 - 0h
-
86 - Food Pesticide Residues — A Conversation with Sheryl Dolan and Meibao Zhuang, Ph.D.Thu, 07 Jul 2022 - 0h
-
85 - Balancing Wildlife Protection and Responsible Pesticide Use — A Conversation with EPA’s Jake LiThu, 23 Jun 2022
-
84 - OEHHA and Prop 65 Update — A Conversation with Lisa R. BurchiThu, 09 Jun 2022 - 0h
-
83 - GHS Update — A Conversation with Karin BaronThu, 26 May 2022 - 0h
-
82 - Trends in Product Sustainability and Circularity — A Conversation with Kate SellersThu, 12 May 2022 - 0h
